Description

Cytarabine (Cytarabine) 100 mg/ml, Solution for Injection

Cytarabine is an antineoplastic cytostatic medicinal product from the group of antimetabolites, widely used in onco-hematological practice as part of chemotherapy regimens. The medicine is intended for the treatment of malignant diseases of the hematopoietic system and is used exclusively on the recommendation of a medical specialist.

The product is available in the form of a solution for injection and is intended for intravenous and subcutaneous administration, in hospital settings under continuous medical supervision.

⭐ Key Product Information

✔ Dosage form: solution for injection
✔ Active ingredient: cytarabine (Cytarabine)
✔ Concentration: 100 mg/ml
✔ Pharmacological group: antimetabolites
✔ Category: antineoplastic (cytostatic) medicines
✔ Prescription status: prescription-only
✔ Use: strictly as prescribed by a physician

⭐ Use in Clinical Practice

Cytarabine is used as monotherapy or in combination with other antineoplastic agents as part of comprehensive treatment for:

✔ acute myeloid leukemia
✔ acute lymphoblastic leukemia
✔ certain forms of chronic leukemias
✔ other onco-hematological diseases (as determined by the physician)

🟦 Onco-hematological diseases are characterized by disruption of normal hematopoiesis and uncontrolled proliferation of pathological cells, requiring specialized cytostatic therapy.

⭐ Mechanism of Action

The mechanism of action of cytarabine is based on inhibition of DNA synthesis in actively dividing cells. The drug interferes with DNA replication processes, leading to suppression of proliferation and death of malignant cells.

The highest activity of the drug is observed during the S phase of the cell cycle, making it effective against rapidly proliferating tumor cells.

❗ Important Information

The decision to use this medicinal product is made exclusively by a physician, taking into account the diagnosis, clinical condition of the patient, and the selected treatment regimen.

⭐ Additional Information

🔹 The medicine is prescription-only
🔹 Primarily used in hospital settings
🔹 Administered under the supervision of an oncologist or hematologist
🔹 Information provided is for reference purposes only
🔹 Not a substitute for professional medical advice